With 21 locations world-wide, Phillips-Medisize, a Molex company, employs over 5,400 people, with over 2,000 of which are located in the U.S. As an organization, we are committed to providing equal employment and advancement to all qualified persons.
Overview
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 10, 2024 | SymPhysis Medical: Pioneering Independence for Cancer Patients with Innovative Drainage Device | In the world of medical technology, innovation often emerges from necessity. SymPhysis Medical, a Galway-based company, embodies this principle. With a recent funding boost of $2.4 million, the company is on a mission to transform the lives... |
| Oct 8, 2024 | Report: SymPhysis Medical raises $2.4M to support cancer device | The Releaze drainage system. [Image from the SymPhysis website]SymPhysis Medical raised $2.4 million (€2.2 million) to support its Releaze drainage system for cancer patients, RTE reports. According to the report, the funding follows a $1.6... |
| Mar 1, 2023 | Thixomolding Technology: The Benefits of using Magnesium in Design & Tooling, Upcoming Webinar Hosted by Xtalks | the process is also more environmental- and worker-friendly TORONTO (PRWEB) March 01, 2023 There is a need for durable, lightweight products in manufacturing and the use of magnesium in injection molding has especially seen significant grow... |
| Jan 27, 2022 | How Phillips-Medisize helped Sotech Health develop a breath analyzer for COVID-19 | Sotech Health and Phillips-Medisize claim the breath analyzer can detect traces of the virus that causes COVID-19 within 30 seconds. [Image courtesy of Phillips-Medisize and Sotech Health]Medtech contract manufacturing giant Phillips-Medisi... |
| Oct 25, 2021 | Drug Handling Capabilities and Serialization Support, Upcoming Webinar Hosted by Xtalks | As the Drug Quality and Security Act (DQSA) is phased into manufacturing operations, contract manufacturers will be required to implement unit-level traceability into their manufacturing processes within the next few years. TORONTO (PRWEB) ... |
| Jul 14, 2021 | Wearable Bolus Injectors: Balancing Stakeholder Needs and Overcoming Barriers to Entry, Upcoming Webinar Hosted by Xtalks | The market for such devices remains immature and faces persistent challenges from well-established autoinjectors and a new cohort of larger payload, more sustainable autoinjector variants. TORONTO (PRWEB) July 14, 2021 Until now, biologics ... |
| Jun 1, 2021 | Improving the Environmental Sustainability of Emerging Autoinjectors, Upcoming Webinar Hosted by Xtalks | Here, we offer data demonstrating improved sustainability of a semi-reusable device, a “smart autoinjector”, over historical autoinjector devices. TORONTO (PRWEB) June 01, 2021 Sustainability in pharmaceuticals and medical devices is a driv... |
| May 13, 2020 | Sense: Koch partner to develop rapid COVID-19 test | Sense of urgency: Koch partnering to develop rapid COVID-19 test Article by Koch Newsroom Phillips-Medisize is helping Sense Biodetection produce a first-of-its-kind molecular diagnostic test that can be administered anywhere and provides a... |
| Feb 20, 2019 | Phillips-Medisize is offering connected health data services: Here’s how | One of the world’s largest medical device contract manufacturers, Phillips-Medisize is making a business play to provide the technological back end for connected drug delivery devices. [Image courtesy of Phillips-Medisize]Phillips-Medisize ... |
Reviews 0
FAQ about Phillips-Medisize
When was Phillips-Medisize founded?
Phillips-Medisize was founded in 1964.
What has the press written about Phillips-Medisize?
Parsers VC has collected 11 articles mentioning Phillips-Medisize, among them “SymPhysis Medical: Pioneering Independence for Cancer Patients with Innovative Drainage Device” (Oct 10, 2024) and “Report: SymPhysis Medical raises $2.4M to support cancer device” (Oct 8, 2024).
Is Phillips-Medisize still active?
Yes, Phillips-Medisize is active; its latest activity on Parsers VC dates from Nov 5, 2026.